Peregrine Asset Advisers, Inc.
Source: SEC Form 13F · as of Mar 2026Peregrine Asset Advisers, Inc. holds 13 biotech & pharma companies tracked by BioSniper, totaling $13.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$13.0M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 2,875 | $2.6M |
| JNJJOHNSON & JOHNSON | 10,551 | $2.6M |
| MRKMerck & Co., Inc. | 14,278 | $1.7M |
| BMYBRISTOL MYERS SQUIBB CO | 24,747 | $1.5M |
| ABBVAbbVie Inc. | 6,121 | $1.3M |
| AMGNAMGEN INC | 2,801 | $986K |
| AZNASTRAZENECA PLC | 2,450 | $483K |
| PMPhilip Morris International Inc | 2,543 | $421K |
| IDXXIDEXX LABORATORIES INC /DE | 682 | $383K |
| ABTABBOTT LABORATORIES | 3,694 | $379K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 582 | $260K |
| DVADaVita Inc. | 1,500 | $231K |
| CTMXCytomX Therapeutics, Inc. | 10,200 | $48K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.